BFM
CVAC

Boothbay Fund Management’s CureVac CVAC Stock Holding History

Boothbay Fund Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-213,800
Closed -$1.29M – 2201
2022
Q4 		$1.29M Buy
+213,800
New +$1.58M 0.03% 791
2021
Q2 		– Sell
-117
Closed -$1.07M – 1898
2021
Q1 		$1.07M Buy
+117
New +$11.3K 0.04% 564

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Boothbay Fund Management's CVAC Position: Q4 2024 in Review

Boothbay Fund Management sold out of CureVac (CVAC) in Q4 2024, closing a stake of 113,200 shares — an estimated $333K sold.

Boothbay Fund Management first reported a position in CVAC in Q3 2024 and held it in 1 quarter. The position peaked at $333K in Q3 2024. 75 funds tracked by Wall St. Rank hold CVAC as of Q4 2024.

  • Boothbay Fund Management reported no remaining CureVac position as of Q4 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 113,200 CureVac shares in Q4 2024, an estimated $333K.
  • Boothbay Fund Management first reported a position in CureVac in Q3 2024 and held it in 1 quarter.
  • Boothbay Fund Management's CureVac position peaked at $333K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held CureVac as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.